National Bank of Canada
COLL icon

National Bank of Canada’s Collegium Pharmaceutical COLL Stock Holding History

National Bank of Canada’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-59,400
Closed -$1.86M – 2761
2023
Q4 		$1.86M Buy
+59,400
New +$1.49M ﹤0.01% 1021

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

National Bank of Canada's COLL Position: Q1 2024 in Review

National Bank of Canada sold out of Collegium Pharmaceutical (COLL) in Q1 2024, closing a stake of 59,400 shares — an estimated $1.86M sold.

National Bank of Canada first reported a position in COLL in Q4 2023 and held it in 1 quarter. The position peaked at $1.86M in Q4 2023. 228 funds tracked by Wall St. Rank hold COLL as of Q1 2024.

  • National Bank of Canada reported no remaining Collegium Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • National Bank of Canada sold 59,400 Collegium Pharmaceutical shares in Q1 2024, an estimated $1.86M.
  • National Bank of Canada first reported a position in Collegium Pharmaceutical in Q4 2023 and held it in 1 quarter.
  • National Bank of Canada's Collegium Pharmaceutical position peaked at $1.86M in Q4 2023.
  • 228 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2024.

Based on National Bank of Canada's 13F filing for Q1 2024, filed 13 May 2024.